DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Slamon DJ, Neven P, Cjia S. et al.
Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. MONALEESA-3.
J Clin Oncol 2018;
36: 2465-2472
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.